Pillstats
Rx only · Injection, Solution · Intramuscular

Tobramycin Sulfate

Brands: Tobramycin · Tobramycin Sulfate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers1 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.234$0.468$0.702$0.937Dec 2025Apr 2026Jul 2026
$0.650
Latest avg · Jul 22, 2026
-20%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1452914365822025 Q12025 Q22025 Q32025 Q42026 Q1
398
Rx · 2026 Q1
22K
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.